CEO and president of first psychedelic ETF, PSYK, says web traffic is up almost 50% as the new sector gains hype from investors

Investing in magic mushrooms: First psychedelic ETF debuts in Toronto

Horizons ETFs Management debuted PSYK in January 2020, an index of 17 Canadian and US life sciences companies focused on therapeutic applications of psychedelic drugs. President and CEO, Steve Hawkins, says “we haven’t seen this kind of hype for a new sector of the equity marketplace since cannabis in 2017” and predicts that the market is going to grow very rapidly. Hawkins says web traffic is up almost 50% and that the ETF is seeing very good traction from a press and media perspective.

PDF of article